News

4-19-21 Let’s get vaccinated! People age 16 + who live, work, or study in Massachusetts can be vaccinated.

4-12-21 Congratulations to Amy Sarma who received the MGH Medicine Innovation Pilot Grant Award for her research on “Virtual Cardiac Rehabilitation Program Following Hypertensive Disorders of Pregnancy”!

4-12-21 Congratulations! MGH awarded Romit Bhattacharya with the Primary Care Innovation Fund Pilot Grant Award for his research on “Validation of a novel toilet seat-based cuffless blood pressure measurement technology and association with left ventricular mass index.”

4-12-21 The most recent paper published by the Natarajan Lab in Nature Communications “Chromosome Xq23 is associated with lower atherogenic lipid concentrations and favorable cardiometabolic indices“.

4-8-21 Congratulations to Maryam Zekavat for winning a SAC 2021 Poster of Distinction Award from MGH!

3-29-2021 Dr. Natarajan would like to announce the launch of his latest trial “Disease Management Platform for Heart Failure” in collaboration with AstraZeneca.

3-19-2021 Congratulations! The editorial board for the MGH Cardiology Board Review Book (2nd edition) awarded Romit Bhattacharya and Pradeep Natarajan for the best chapter.

03-17-2021 Massachusetts released the latest vaccine schedule. Beginning April 19th, all groups are eligible to receive the vaccine.

03-11-2021 Our latest preprint! “A large-scale multi-ethnic genome-wide association study of coronary artery disease”

03-10-2021 Our latest paper from the lab! “Association of Premature Menopause With Incident Pulmonary Hypertension: a cohort study”

03-10-2021 Welcome to our latest lab members! So Mi Jemma Cho who comes from the Republic of Korea and Abraham Cheloff a medical student at Harvard Medical School.

03-08-2021 New guidelines from @CDCgov for vaccinated adults.

03-05-2021  The University of Texas, Southwestern Medical Center, Department of Internal Medicine awarded Dr. Natarajan the 2021 Bromberg Memorial Visiting Professorship. During Grand Rounds, he presented his work on “Cardiovascular Precision Medicine and Dynamic Genomes”.

Welcome!

Cardiovascular disease, largely due to coronary artery disease, is the leading cause of death in the United States and worldwide.

Our laboratory uses genomics, biomarkers, bioinformatics, mobile technology, and deep phenotyping to discover and understand the causal factors of atherosclerotic cardiovascular disease across diverse populations. We also implement these insights in prospective studies to improve preventive cardiovascular care.

Our laboratory spans the Massachusetts General Hospital Cardiovascular Research Center and Center for Genomic Medicine, Program in Medical & Population Genetics of the Broad Institute of Harvard and MIT, and Harvard Medical School.

Our work is possible through support of funders, and collaborations with scientists and research participants around the world.

Dr. Natarajan is also the Director of Preventive Cardiology at Massachusetts General Hospital where he oversees prevention, genetics, and cardiac rehabilitation programs for atherosclerotic cardiovascular disease.

© Copyright 2018 Natarajan Lab | Designed and maintained by Pradeep Natarajan
Flat color icons by Icons8